Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/24/2025

Pleural Fluid Analysis for Pleural Effusion

Essential Initial Tests

  • The British Thoracic Society recommends that all pleural fluid samples should be analyzed for protein, LDH, pH, cytology, Gram stain, acid-fast bacilli (AAFB) stain, and microbiological culture, with samples sent in both sterile containers and blood culture bottles to maximize diagnostic yield 1, 2, 3
  • Measure pleural fluid protein to differentiate transudates from exudates, using Light's criteria when protein is borderline (25-35 g/L) 2, 3
  • Perform pH measurement in all non-purulent effusions when infection is suspected; pH <7.2 indicates complicated parapneumonic effusion requiring drainage 2, 3

Microbiological Studies

  • Send 5-10 mL in aerobic and anaerobic blood culture bottles PLUS sterile containers for Gram stain, AAFB stain, and TB culture 1, 4, 3
  • When volume is limited (2-5 mL), prioritize blood culture bottles over plain containers 1, 4

Cytological Examination

  • Submit 25-50 mL for cytological analysis in suspected malignancy (strong recommendation by consensus) 1, 4
  • Use both direct smear and cell block preparation 1, 4
  • Cytology detects only 60% of malignant effusions; negative results should prompt further investigation 2, 3

Specialized Tests Based on Clinical Context

For Suspected Tuberculosis

  • Consider adenosine deaminase (ADA) in high prevalence populations (>35-45 U/L with >50% lymphocytes suggests TB); use as exclusion test in low prevalence areas 1, 4, 5
  • Interferon-gamma (IFN-γ) can be measured with 89% sensitivity and 97% specificity 5
  • Tissue sampling is strongly recommended as preferred diagnostic approach for all suspected TB cases (69-97% sensitivity) 1, 4, 5

For Suspected Malignancy

  • Cytology sensitivity varies by tumor type: direct biopsies should be considered for tumors with low cytological yield (especially mesothelioma) 1, 4
  • Pleural fluid biomarkers should NOT be routinely used for diagnosing secondary pleural malignancy 1, 4

For Suspected Heart Failure

  • Serum NT-proBNP should be measured to support diagnosis in unilateral effusions suspected of heart failure (conditional recommendation) 1, 4
  • Pleural fluid NT-proBNP is not superior to serum levels and should not be ordered routinely 1, 4

Fluid Appearance Assessment

Visual Inspection

  • Note appearance and odor: serous, blood-tinged, frankly bloody, or purulent 2, 3
  • Turbid/milky fluid: centrifuge to differentiate empyema (clear supernatant) from chylothorax (turbid supernatant due to lipids) 2, 3
  • Hemorrhagic fluid: measure hematocrit if hemothorax suspected; pleural fluid hematocrit >50% of peripheral blood confirms hemothorax 2, 3

Procedural Recommendations

Thoracentesis Technique

  • Image guidance should ALWAYS be used to reduce complications (strong recommendation by consensus) 1, 4
  • Use fine-bore 21G needle with 50 mL syringe 2, 3

Diagnostic Algorithm

  • Determine if transudate likely (heart failure, hypoalbuminemia, dialysis) 2, 3, 6
  • If transudate suspected: treat underlying cause; perform thoracentesis only if atypical features or no response 6
  • Perform thoracentesis: send for all core tests listed above 2, 3
  • Classify as transudate vs exudate: use protein levels and Light's criteria when borderline 2, 3
  • If exudate without diagnosis: proceed to contrast-enhanced CT thorax and consider pleural biopsy (ultrasound/CT-guided, closed, or thoracoscopic) 2, 3, 6